Mark Baldry

Inga fler pågående positioner

Förmögenhet: 109 202 $ per 2026-05-31

62 år

17 relationer

Health Technology

Consumer Services

Utilities

Profil

Mark Baldry formerly worked at Biogen, Inc., as Vice President-New Product Commercialization, Amicus Therapeutics, Inc., as SVP-Global Marketing & Commercial Operations, Shire Plc, as Head-Marketing & Market Access EMEA, Wave Life Sciences Ltd., as Chief Commercial Officer, Freeline Therapeutics Holdings Ltd., as Chief Commercial Officer from 2020 to 2022, Wave Life Sciences USA, Inc., as Chief Commercial Officer from 2019 to 2020, and X4 Pharmaceuticals, Inc., as Chief Commercial Officer from 2022 to 2025.
Mr. Baldry received his undergraduate degree from York University and Masters Business Admin degree from Concordia University.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
X4 PHARMACEUTICALS, INC. 0,03 %	2025-05-16	25 337 ( 0,03 % )	109 202 $	2026-05-31

Tidigare kända positioner av Mark Baldry

Företag	Position	Slut
X4 PHARMACEUTICALS, INC.	Företagsledare/Principal	2025-09-15
FREELINE THERAPEUTICS HOLDINGS PLC	Företagsledare/Principal	2022-10-01
Wave Life Sciences USA, Inc. Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics	Företagsledare/Principal	2020-02-01
AMICUS THERAPEUTICS, INC.	Försäljning & Marknadsföring	2019-07-01
BIOGEN INC.	Offentlig kommunikationskontakt	2015-05-01

Se detaljerna i Mark Baldrys erfarenhet

Mark Baldrys utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Mark Baldrys erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	9
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Amicus Therapeutics, Inc. Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases	Health Technology
Shire Plc Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases	Health Technology
Wave Life Sciences Ltd. Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines	Health Technology
York University York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Concordia University Concordia University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Wave Life Sciences USA, Inc. Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Provides nucleic acid therapeutics	Utilities
X4 Pharmaceuticals, Inc. X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases	Health Technology
Freeline Therapeutics Holdings Plc Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Develops and manufactures next-generation gene therapies	Health Technology